Cerus | CERS - Operating Expenses

Stock Price
2.07
Daily Change
-0.18 -7.81%
Monthly
-3.50%
Yearly
28.26%
Q1 Forecast
2.48

Cerus reported $34.78M in Operating Expenses for its fiscal quarter ending in December of 2024.





Operating Expenses Change Date
Cerus USD 34.78M 2.98M Dec/2024
GRIFOLS EUR 1.71B 193M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Neogen USD 230.07M 4.79M Sep/2025
OraSure Technologies USD 23.07M 4.36M Sep/2024
Quidel USD 760.9M 1.28B Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Utah Medical Products USD 6.25M 80K Sep/2024